The Miami VA Healthcare System (MVAHS) is honored and privileged to have been selected to participate in a new national research initiative. The Department of Veterans Affairs Office of Research and Development is launching the Million Veteran Program (MVP): A Partnership with Veterans. The goal of MVP is to better understand how genes affect health and illness in order to improve health care for Veterans.
MVP is a research program that will allow current Veterans to help transform health care, not only for themselves, but for future generations of Veterans. MVP aims to be one of the largest studies of genes and health in the United States with an expected enrollment of one million Veterans over the next five to seven year period. MVP will establish one of the largest databases of genetic and health information to be used for future studies that may lead to new ways of preventing and treating illnesses in Veterans and all Americans.
Participation in MVP is entirely voluntary and will not in any way affect Veterans’ access to health care or benefits. MVP has extensive safeguards in-place to ensure information security and patient confidentiality are top priorities. MVP is a research program that could allow current Veterans to help transform health care, not only for themselves, but for future generations of Veterans.
In order to do this, MVP will establish one of the largest databases of genetic, military exposure, lifestyle, and health information. Research findings based on MVP may lead to new ways of preventing and treating illnesses in Veterans. Such findings may help answer questions like "Why does a treatment work well for some Veterans but not for others?"; "Why are some Veterans at a greater risk for developing an illness?" and "How can we prevent certain illnesses in the first place?" With the expected enrollment of one million Veterans over the next five to seven years, MVP aims to be one of the largest databases of its kind in the United States.
For more information, visit http://www.research.va.gov/mvp/.
